Cargando…

Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery

OBJECTIVE: The role of surgery in metastatic colorectal cancer (mCRC) remains controversial. This study was performed to assess the impact of surgery on survival in metastatic colorectal cancer. MATERIALS AND METHODS: Information of mCRC patients diagnosed between January 1, 2004, and December 31, 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao-Fen, Tan, Yi-Nuo, Zhong, Chen-Han, Zhu, Li-Zhen, Fang, Xue-Feng, Li, Jun, Ding, Ke-Feng, Yuan, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668074/ https://www.ncbi.nlm.nih.gov/pubmed/29108341 http://dx.doi.org/10.18632/oncotarget.18896

Ejemplares similares

Right- and left-sided colorectal cancers respond differently to cetuximab
por: Wang, Feng, et al.
Publicado: (2015)

Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors
por: Sunakawa, Yu, et al.
Publicado: (2018)

Comprehensive analysis of the differences between left- and right-side colorectal cancer and respective prognostic prediction
por: Niu, Mengye, et al.
Publicado: (2022)

Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens
por: Arikan, Rukiye, et al.
Publicado: (2023)

The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer
por: Zhang, Yu, et al.
Publicado: (2021)

The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis
por: Yuan, Zi-Xu, et al.
Publicado: (2013)

Right- and left-sided colorectal cancers respond differently to traditional Chinese medicine
por: Liu, Shan-Shan, et al.
Publicado: (2017)

Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer
por: Hu, Yue, et al.
Publicado: (2022)

Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy
por: Ulivi, Paola, et al.
Publicado: (2017)

Evaluation of characteristics of left-sided colorectal perfusion in elderly patients by angiography
por: Zhang, Chao, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of First-Line FOLFIRI Combined With Cetuximab or Bevacizumab in Patients With RAS Wild-Type Left-Sided Metastatic Colorectal Cancer
por: Han, Jiaqi, et al.
Publicado: (2020)

Comparison of survival between right‐sided and left‐sided colon cancer in different situations
por: Qiu, Miao‐Zhen, et al.
Publicado: (2018)

Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer
por: Huang, Ching-Wen, et al.
Publicado: (2015)

Resolving the difference between left-sided and right-sided colorectal cancer by single-cell sequencing
por: Guo, Wei, et al.
Publicado: (2022)

Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer
por: Correale, Pierpaolo, et al.
Publicado: (2012)

Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer
por: Kubeček, Ondřej, et al.
Publicado: (2021)

Construction of a long noncoding RNA-based competing endogenous RNA network and prognostic signatures of left- and right-side colon cancer
por: Li, Ke-zhi, et al.
Publicado: (2021)

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial
por: von Einem, J. C., et al.
Publicado: (2014)

Genomic and Metabolomic Landscape of Right-Sided and Left-Sided Colorectal Cancer: Potential Preventive Biomarkers
por: Su, Ming-Wei, et al.
Publicado: (2022)

Coexpression of SFRP1 and WIF1 as a Prognostic Predictor of Favorable Outcomes in Patients with Colorectal Carcinoma
por: Huang, Shiyong, et al.
Publicado: (2014)

Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character
por: Crespo, Ainara, et al.
Publicado: (2018)

IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab
por: Marisi, Giorgia, et al.
Publicado: (2018)

Differences in oncological outcomes and inflammatory biomarkers between right‐sided and left‐sided stage I‐III colorectal adenocarcinoma
por: Guo, Dongming, et al.
Publicado: (2019)

Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
por: Nissen, Neel I., et al.
Publicado: (2021)

Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer Therapy
por: Yang, Xiuyan, et al.
Publicado: (2021)

Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy
por: Lin, Gui-Nan, et al.
Publicado: (2016)

Predictive value of prognostic nutritional and systemic immune-inflammation indices for patients with microsatellite instability-high metastatic colorectal cancer receiving immunotherapy
por: Yi, Jiahong, et al.
Publicado: (2023)

Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy
por: Zhang, Hang-Yu, et al.
Publicado: (2018)

Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?
por: Chen, Xinyang, et al.
Publicado: (2023)

Surgical Treatment of Obstructed Left-Sided Colorectal Cancer Patients
por: Kim, Young Jin
Publicado: (2014)

Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer
por: Nicolazzo, Chiara, et al.
Publicado: (2019)

Molecular differences in the microsatellite stable phenotype between left‐sided and right‐sided colorectal cancer
por: Takahashi, Yayoi, et al.
Publicado: (2016)

Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature
por: Baran, Burcin, et al.
Publicado: (2018)

Development and Validation of the Individualized Prognostic Nomograms in Patients With Right- and Left-Sided Colon Cancer
por: Luo, Zai, et al.
Publicado: (2021)

The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon
por: Lee, Kun-Han, et al.
Publicado: (2021)

The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy
por: Cai, Changjing, et al.
Publicado: (2022)

Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis
por: Wang, Bingyan, et al.
Publicado: (2019)

Colorectal adenocarcinoma in Uganda: are right-sided and left-sided colon cancers two distinct disease entities?
por: Wismayer, Richard, et al.
Publicado: (2023)

Differences in DNA damage repair gene mutations between left‐ and right‐sided colorectal cancer
por: Huang, Wei, et al.
Publicado: (2023)

High Myeloperoxidase Positive Cell Infiltration in Colorectal Cancer Is an Independent Favorable Prognostic Factor
por: Droeser, Raoul A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k6j38lmacucbakkftat1a920db